Sanofi S.A.

This fund shows that industry expertise can help you make a lot of money in the stock market

12:28 p.m. Oct. 2, 2023

- Philip van Doorn

First Wave BioPharma stock soars in active trading after Sanofi license deal

7:07 a.m. Sept. 14, 2023

- Tomi Kilgore

LVMH joins top-tier French sponsors of 2024 Paris Olympics and Paralympics

11:02 p.m. July 24, 2023

- Associated Press

GSK shares surge after reaching settlement on Zantac ahead of California trial

5:05 a.m. June 23, 2023

- Steve Goldstein

Coinbase’s stock tumbles after SEC warning, Regeneron shares rally, and other stocks on the move

2:01 p.m. March 23, 2023

- Barbara Kollmeyer

The Fed pivot is near, and yield curve inversion has likely peaked. That’s usually bad news for stocks, this Fidelity strategist says.

8:49 a.m. March 23, 2023

- Steve Goldstein

Sanofi to cap price of Lantus insulin at $35

4:24 p.m. March 16, 2023

- Jaimy Lee

Regional banks pace decliners after bank failures, as biotech deals lift Seagen and Provention Bio

3:22 p.m. March 13, 2023

- Steve Goldstein

SVB’s rescue means the Fed won’t hike rates in March, says Goldman Sachs

10:23 a.m. March 13, 2023

- Barbara Kollmeyer

Sanofi to buy Provention Bio in deal worth $2.9 billion

6:38 a.m. March 13, 2023

- Barbara Kollmeyer

Regeneron, Sanofi’s Dupixent is one step closer to approval for young children in Europe

9:27 a.m. Jan. 27, 2023

- Jaimy Lee

Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns than research

2:40 p.m. Jan. 14, 2023

- Ciara Linnane

Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio

8:47 a.m. Dec. 13, 2022

- Ciara Linnane

Amgen reportedly in talks to buy Horizon Therapeutics

2:36 a.m. Dec. 12, 2022

- Ben Dummett

Banks are short more than $1 trillion in capital, says this analyst, who fears the shortfall will only get worse

9:20 a.m. Dec. 1, 2022

- Steve Goldstein

China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day

2:55 p.m. Nov. 11, 2022

- Ciara Linnane

Sanofi posts higher sales but $2.07 billion net profit misses forecasts

2:09 a.m. Oct. 28, 2022

- Cecilia Butini

AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say

7:48 a.m. Sept. 14, 2022

- Anviksha Patel

Zantac lawsuit drop ‘not as significant as it appears’ for GSK stock, analysts say

7:09 a.m. Aug. 17, 2022

- Anviksha Patel

GSK defends Zantac ahead of trials that have wiped off $44 billion from leading drugmakers

3:24 p.m. Aug. 12, 2022

- Steve Goldstein

Big Drugmakers Pay Big Prices for Promising Biotechs

8:12 a.m. Jan. 23, 2018

- The Wall Street Journal Interactive Edition

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition

Philippines Probes Dengue Vaccination Drive That Went Ahead Despite Warnings

12:03 p.m. Dec. 18, 2017

- The Wall Street Journal Interactive Edition

FDA Panel Expands Flu Vaccine

9:31 p.m. Feb. 27, 2013

- The Wall Street Journal Interactive Edition

Many Past Espionage Cases Had Links to China

12:28 p.m. Feb. 21, 2013

- The Wall Street Journal Interactive Edition

French Stock Benchmark Regains Its Spring

8:55 p.m. Feb. 29, 2012

- The Wall Street Journal Interactive Edition

FDA Restricts Use of Multaq

4:49 p.m. Dec. 19, 2011

- The Wall Street Journal Interactive Edition

In 2012, Slow Return to European Stocks

10:26 p.m. Dec. 18, 2011

- The Wall Street Journal Interactive Edition

Sanofi Profit Climbs 26%

3:32 p.m. Nov. 3, 2011

- The Wall Street Journal Interactive Edition

Sanofi Offers Bonuses to Retain Genzyme Scientists

9:44 a.m. April 28, 2011

- The Wall Street Journal Interactive Edition

Roche Sales Fall 9%

4:08 p.m. April 14, 2011

- The Wall Street Journal Interactive Edition

Key Drugs Boost AstraZeneca

5:17 a.m. July 29, 2010

- The Wall Street Journal Interactive Edition

Corporate Watch

10:16 p.m. April 6, 2010

- The Wall Street Journal Interactive Edition

Sanofi Settles More Patent Suits

7:27 a.m. April 6, 2010

- The Wall Street Journal Interactive Edition

Earnings Watch

8:36 p.m. Feb. 10, 2010

- The Wall Street Journal Interactive Edition

Key Drug Sales, Vaccines Boost Sanofi

11:13 a.m. Feb. 10, 2010

- The Wall Street Journal Interactive Edition

Energy Firms Lead European Markets

1:45 p.m. Dec. 21, 2009

- The Wall Street Journal Interactive Edition

Bristol-Myers to Split Off Mead

8:00 a.m. Nov. 16, 2009

- The Wall Street Journal Interactive Edition

Weak Data Weigh Down Europe's Indexes

12:45 p.m. Sept. 1, 2009

- The Wall Street Journal Interactive Edition

European Shares Follow Asia Lower

8:06 p.m. Aug. 31, 2009

- The Wall Street Journal Interactive Edition